Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018

BACKGROUND: Relatively high rates of adherence to myocardial infarction (MI) secondary prevention medications have been reported, but register-based, objective real-world data is scarce. We aimed to analyse adherence to guideline-recommended medications for secondary prevention of MI in 2017 to 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Lõiveke, Piret, Marandi, Toomas, Ainla, Tiia, Fischer, Krista, Eha, Jaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527758/
https://www.ncbi.nlm.nih.gov/pubmed/34670499
http://dx.doi.org/10.1186/s12872-021-02321-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527758/
https://www.ncbi.nlm.nih.gov/pubmed/34670499
http://dx.doi.org/10.1186/s12872-021-02321-x

Ejemplares similares